Dimethyl Fumarate for Obstructive Sleep Apnea

PHASE2CompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

April 30, 2016

Study Completion Date

May 31, 2016

Conditions
Obstructive Sleep ApneaOSASleep Apnea
Interventions
DRUG

Dimethyl fumarate

Dimethyl fumarate capsules will be dispensed during routine study appointments. 120 mg tablets will be dispensed to facilitate dose titrations. Drug will be dispensed in 1 month supply, so that compliance can be reconciled at monthly follow-up visits, and recorded in accountability logs. Participants will be instructed to take the medication with food, in the morning and at dinnertime. If participants miss a dose, they will be instructed to resume their normal dose at the next scheduled time, and be instructed not to take an extra dose at their next dosing interval if they previously miss a dose.

DRUG

Placebo

Placebo capsules will be dispensed during routine study appointments. Placebo will be dispensed in 1 month supply, so that compliance can be reconciled at monthly follow-up visits, and recorded in accountability logs. Participants will be instructed to take the placebo with food, in the morning and at dinnertime. If participants miss a dose, they will be instructed to resume their normal dose at the next scheduled time, and be instructed not to take an extra dose at their next dosing interval if they previously miss a dose.

Trial Locations (1)

48109

University of Michigan, Ann Arbor

All Listed Sponsors
lead

University of Michigan

OTHER

NCT02438137 - Dimethyl Fumarate for Obstructive Sleep Apnea | Biotech Hunter | Biotech Hunter